Loading…

HERITAGE: a phase III safety and efficacy trial of the proposed trastuzumab biosimilar Myl-1401O versus herceptin

Saved in:

Bibliographic Details
Published in:	European journal of cancer (1990) 2017-02, Vol.72, p.S41-S41
Main Authors:	Rugo, H, Barve, A, Waller, C, Bronchud, M.H, Herson, J, Yuan, J, Manikhas, A, Bondarenko, I, Mukhametshina, G, Nemsadze, G, Parra, J, Abesamis Tiambeng, M.L, Baramidze, K, Akewanlop, C, Vynnychenko, I, Sriuranpong, V, Mamillapalli, G, Ray, S, Yanez Ruiz, E.P, Pennella, E
Format:	Article
Language:	English
Subjects:	Hematology, Oncology and Palliative Medicine
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!